Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics

NCT03790345 is registered in ClinicalTrials.gov with Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03790345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
Lead sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 3, 2019
Completion date
November 3, 2021
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug induced movement disorder, unspecified, oxidative stress, schizophrenia